Attached files
file | filename |
---|---|
10-Q - FORM 10-Q - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-033113.htm |
EX-31.1 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex3101.htm |
EX-31.2 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex3102.htm |
EX-32.2 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex3202.htm |
EX-10.1 - AMENDMENT TO CONSULTING AGREEMENT - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex1001.htm |
EXCEL - IDEA: XBRL DOCUMENT - Brooklyn ImmunoTherapeutics, Inc. | Financial_Report.xls |
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of NTN Buzztime, Inc. (the “Registrant”) on Form 10-Q for the period ended March 31, 2013 (the “Report”), I, Jeff Berg, Interim Chief Executive Officer of the Registrant, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) | the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. |
Dated: May 13, 2013 |
/s/ Jeff Berg |
Jeff Berg | |
Interim Chief Executive Officer | |
NTN Buzztime, Inc. |